Murphy Capital Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $258K | Buy |
3,055
+64
| +2% | +$5.62K | 0.04% | 190 |
|
|
2022
Q1 | $262K | Sell |
2,991
-97
| -3% | -$8.4K | 0.03% | 202 |
|
|
2021
Q4 | $270K | Sell |
3,088
-50
| -2% | -$4.15K | 0.03% | 203 |
|
|
2021
Q3 | $256K | Sell |
3,138
-650
| -17% | -$58.5K | 0.03% | 203 |
|
|
2021
Q2 | $345K | Sell |
3,788
-1,050
| -22% | -$93.5K | 0.04% | 181 |
|
|
2021
Q1 | $413K | Sell |
4,838
-57
| -1% | -$5.12K | 0.05% | 159 |
|
|
2020
Q4 | $462K | Sell |
4,895
-1,150
| -19% | -$100K | 0.06% | 142 |
|
|
2020
Q3 | $525K | Sell |
6,045
-490
| -7% | -$42.4K | 0.08% | 134 |
|
|
2020
Q2 | $570K | Buy |
6,535
+440
| +7% | +$38K | 0.09% | 131 |
|
|
2020
Q1 | $502K | Hold |
6,095
| – | – | 0.1% | 133 |
|
|
2019
Q4 | $577K | Hold |
6,095
| – | – | 0.08% | 147 |
|
|
2019
Q3 | $529K | Sell |
6,095
-360
| -6% | -$32.3K | 0.08% | 152 |
|
|
2019
Q2 | $589K | Sell |
6,455
-1,452
| -18% | -$123K | 0.09% | 148 |
|
|
2019
Q1 | $681K | Sell |
7,907
-1,116
| -12% | -$89.6K | 0.1% | 141 |
|
|
2018
Q4 | $693K | Sell |
9,023
-1,460
| -14% | -$114K | 0.12% | 137 |
|
|
2018
Q3 | $809K | Sell |
10,483
-3,214
| -23% | -$238K | 0.11% | 141 |
|
|
2018
Q2 | $927K | Sell |
13,697
-202
| -1% | -$13.9K | 0.13% | 135 |
|
|
2018
Q1 | $1.01M | Sell |
13,899
-55
| -0.4% | -$4.19K | 0.14% | 135 |
|
|
2017
Q4 | $1.05M | Buy |
13,954
+390
| +3% | +$29.4K | 0.14% | 131 |
|
|
2017
Q3 | $1.04M | Buy |
13,564
+91
| +0.7% | +$6.87K | 0.15% | 133 |
|
|
2017
Q2 | $1.01M | Sell |
13,473
-112
| -0.8% | -$7.94K | 0.15% | 133 |
|
|
2017
Q1 | $904K | Sell |
13,585
-558
| -4% | -$37.2K | 0.13% | 136 |
|
|
2016
Q4 | $923K | Buy |
14,143
+558
| +4% | +$36.2K | 0.15% | 129 |
|
|
2016
Q3 | $961K | Sell |
13,585
-101
| -0.7% | -$7.36K | 0.15% | 134 |
|
|
2016
Q2 | $1.01M | Buy |
13,686
+1,596
| +13% | +$110K | 0.16% | 135 |
|
|
2016
Q1 | $784K | Sell |
12,090
-1,455
| -11% | -$99K | 0.12% | 150 |
|
|
2015
Q4 | $1.04M | Sell |
13,545
-2,678
| -17% | -$213K | 0.16% | 125 |
|
|
2015
Q3 | $1.34M | Sell |
16,223
-335
| -2% | -$29.8K | 0.22% | 110 |
|
|
2015
Q2 | $1.46M | Sell |
16,558
-101
| -0.6% | -$9.27K | 0.22% | 116 |
|
|
2015
Q1 | $1.47M | Sell |
16,659
-24
| -0.1% | -$2.13K | 0.22% | 114 |
|
|
2014
Q4 | $1.39M | Sell |
16,683
-167
| -1% | -$13.8K | 0.21% | 121 |
|
|
2014
Q3 | $1.42M | Buy |
16,850
+613
| +4% | +$49.6K | 0.22% | 117 |
|
|
2014
Q2 | $1.32M | Buy |
16,237
+1,228
| +8% | +$96.6K | 0.21% | 124 |
|
|
2014
Q1 | $1.14M | Sell |
15,009
-223
| -1% | -$16.3K | 0.19% | 129 |
|
|
2013
Q4 | $1.1M | Buy |
15,232
+60
| +0.4% | +$4.17K | 0.19% | 129 |
|
|
2013
Q3 | $1.04M | Sell |
15,172
-167
| -1% | -$11K | 0.2% | 128 |
|
|
2013
Q2 | $971K | Buy |
+15,339
| New | +$998K | 0.2% | 125 |
|
Other funds holding NVS
Murphy Capital Management's NVS Position: Q2 2022 in Review
Murphy Capital Management increased its Novartis (NVS) stake by 2.1% in Q2 2022, buying an estimated $5.62K and bringing the position to 3,055 shares worth $258K. The position accounts for 0.04% of the portfolio, ranked #190.
Murphy Capital Management first reported a position in NVS in Q2 2013 and has held it in 37 quarters since. The position peaked at $1.47M in Q1 2015. 1,140 funds tracked by Wall St. Rank hold NVS as of Q2 2022.
- Murphy Capital Management held 3,055 shares of Novartis worth $258K as of Q2 2022.
- Murphy Capital Management bought 64 Novartis shares in Q2 2022, an estimated $5.62K.
- Novartis made up 0.04% of Murphy Capital Management's portfolio in Q2 2022, its #190 holding.
- Murphy Capital Management first reported a position in Novartis in Q2 2013 and has held it in 37 quarters since.
- Murphy Capital Management's Novartis position peaked at $1.47M in Q1 2015.
- 1,140 funds tracked by Wall St. Rank held Novartis as of Q2 2022.
Based on Murphy Capital Management's 13F filing for Q2 2022, filed 13 Jul 2022.